Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder...Revenue Sharing Agreement • July 7th, 2021 • Nuvalent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 7th, 2021 Company Industry JurisdictionTHIS AMENDED AND RESTATED REVENUE SHARING AGREEMENT (this “Agreement”) is made and entered into as of February 2, 2017 (the “Effective Date”) by and between Nuvalent, Inc., a Delaware corporation (the “Company”), and Matthew Shair, Ph.D. (the “Founder”).
Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder...Revenue Sharing Agreement • May 28th, 2021 • Nuvalent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 28th, 2021 Company Industry JurisdictionTHIS AMENDED AND RESTATED REVENUE SHARING AGREEMENT (this “Agreement”) is made and entered into as of February 2, 2017 (the “Effective Date”) by and between Nuvalent, Inc., a Delaware corporation (the “Company”), and Matthew Shair, Ph.D. (the “Founder”).